Scandinavian ChemoTech AB Stock: price and insider trades · Sweden
1 insider bought €884 of shares over the last 90 days, the latest by APAC EQUITY MANAGEMENT PTE LTD, filed 28 Sept 2026.
Scandinavian ChemoTech AB: what insiders have been doing
This page follows insider dealings at Scandinavian ChemoTech AB as filed with Finansinspektionen, a company from the Health Care sector. In the past year (30 October 2025 to 30 October 2026), 6 filings came from 4 insiders.
Every open-market trade in the period is a purchase: 3 purchases worth €78k, from 2 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €73k from APAC Equity Management Pte Ltd, disclosed on 3 March 2026. Among those who bought: 2 chief executives.
For context, the typical company on the same exchange (median of 1,035 companies) published 9 filings over the same period, against 6 filings here. Looking back to 2016, when coverage begins, insiders filed 84 purchases and 11 sales.
The latest purchase dates back some time: it was published 41 days ago, on 28 September 2026. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 3,850 shares@ SEK 2.600.010% mcap1.2% of flowAktieISIN SE0009242654FI:csv-b956bcce3e0e5d95fe91Canonical exit: 23 Dec 2026 (T+90)
- 74,626 shares@ SEK 3.350.26% mcap100.0% of flowAktieISIN SE0009382989FI:csv-85d979fefbb0d4a7bde6
- 223,880 shares@ SEK 3.350.79% mcap92.8% of flowAktieISIN SE0009382989FI:csv-00f6ecccfdaced2fe37a
- 238,805 shares@ SEK 3.35100.0% of flowAktieISIN SE0009382989FI:csv-440fd9a78f695a4982a0
- 220,000 shares@ SEK 3.5511.4% of flowAktieISIN SE0009382989FI:csv-2985e4dc0e18967ead2eCanonical exit: 1 Jun 2026 (T+90)
- 12,611 shares@ SEK 3.800.051% mcap6.1% of flowAktieISIN SE0009242654FI:A003U613-1Canonical exit: 11 Mar 2026 (T+90)
- 22,000 shares@ SEK 1.7181.1% of flowAktieISIN SE0009242654FI:csv-092d5c0c77f9f7fd7d58Canonical exit: 6 Mar 2025 (T+90)
- 328,670 shares@ SEK 1.8016.1% of flowBTA (betald tecknad aktie)ISIN SE0022241469FI:csv-e5b90b7806b2b3ba65dbCanonical exit: 26 Sept 2024 (T+90)
- 833,333 shares@ SEK 1.8013.4% of flowBTA (betald tecknad aktie)ISIN SE0022241469FI:csv-1b7d1851cdac43d16938
- 4,760 shares@ SEK 1.8018.9% of flowBTA (betald tecknad aktie)ISIN SE0022241469FI:csv-8b7fb881c5a5dfbf9971
- 226,885 shares@ SEK 1.8011.3% of flowBTA (betald tecknad aktie)ISIN SE0022241469FI:csv-eb7ece2cdfa68e94674fCanonical exit: 16 Sept 2024 (T+90)
- 97,048 shares@ SEK 0.00180.0% of flowTeckningsrätt/UniträttISIN SE0022241451FI:csv-bdbb6da735913b864e00Canonical exit: 10 Sept 2024 (T+90)
- 42,857 shares@ SEK 2.352.8% of flowAktieISIN SE0009242654FI:csv-7ee269f7a0da88a04f06Canonical exit: 26 Mar 2024 (T+90)
- 42,857 shares@ SEK 2.3516.2% of flowAktieISIN SE0009242654FI:csv-a2d6900dca2fcdbac2c5
- 800,000 shares@ SEK 2.5017.6% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-69634d38c5044fff1037
- 344,543 shares@ SEK 2.5023.3% of flowBTA (betald tecknad aktie)ISIN SE0018716458FI:csv-cbc4456aa44565361583Canonical exit: 14 Feb 2024 (T+90)
- 2,858 shares@ SEK 2.5041.1% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-5c01cdcdc37026a5198b
- 35,984 shares@ SEK 2.5020.4% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-a2a749f49f6527473d58
- 2,558 shares@ SEK 2.500.6% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-276cfe161df830fde1e2
- 3,332 shares@ SEK 2.500.1% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-ff52729a09b401815c99
- 2,142 shares@ SEK 2.5030.7% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-af19a9b329881ac09131
- 14,285 shares@ SEK 2.504.2% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-0dd75e549d3803ad0e03
- 10,714 shares@ SEK 2.506.0% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-09b5606d78ee5d51abc9
- 42,600 shares@ SEK 2.502.8% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-353f4f710f8b10253892Canonical exit: 5 Feb 2024 (T+90)
- 12,857 shares@ SEK 2.504.9% of flowBTA (betald tecknad aktie)ISIN SE0020998508FI:csv-9f4934eb1bc5471d2926Canonical exit: 5 Feb 2024 (T+90)
25 of 128 declarations
About Scandinavian ChemoTech AB
Scandinavian ChemoTech AB is a company focused on developing innovative cancer treatments. It specializes in enhanced chemotherapy solutions and targeted treatment technologies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
